Development of a new injectable medication called TAK-243.
NEXT DTP-22-013, PRODUCTION OF TAK-243 INJECTABLE FOR CLINICAL USE
This study is looking at a new injectable medicine called TAK-243 to make sure it stays safe and effective for patients, so they can eventually use it in their treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Irisys, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project ID | NIH-10710314 on NIH RePORTER |
What this research studies
This research focuses on producing TAK-243, an injectable medication intended for clinical use. The project will investigate the stability and shelf-life of this medication to ensure its effectiveness when administered to patients. By ensuring that TAK-243 can be safely stored and used, the research aims to facilitate its availability for patient treatment. Patients may be involved in trials to assess the medication's safety and efficacy once it is ready for clinical application.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals who may benefit from the therapeutic effects of TAK-243.
Not a fit: Patients who do not have conditions that TAK-243 is designed to treat may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with a new treatment option that is stable and effective.
How similar studies have performed: While the production of injectable medications is a common practice, the specific development of TAK-243 is a novel approach that has not been extensively tested in prior studies.
Where this research is happening
San Diego, United States
- Irisys, INC. — San Diego, United States (Active)
Researchers
- Principal investigator: Giannini, Robert — Irisys, INC.
- Study coordinator: Giannini, Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.